Coloplast A/S (CLPBF)
OTCMKTS
· Delayed Price · Currency is USD
108.10
-0.45 (-0.41%)
Feb 21, 2025, 1:59 PM EST
Coloplast Revenue
Coloplast had revenue of 7.03B DKK in the quarter ending December 31, 2024, with 6.36% growth. This brings the company's revenue in the last twelve months to 27.45B, up 9.80% year-over-year. In the fiscal year ending September 30, 2024, Coloplast had annual revenue of 27.03B with 10.33% growth.
Revenue (ttm)
27.45B DKK
Revenue Growth
+9.80%
P/S Ratio
n/a
Revenue / Employee
1.65M DKK
Employees
16,639
Market Cap
25.21B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 27.03B | 2.53B | 10.33% |
| Sep 30, 2023 | 24.50B | 1.92B | 8.51% |
| Sep 30, 2022 | 22.58B | 3.15B | 16.23% |
| Sep 30, 2021 | 19.43B | 882.00M | 4.76% |
| Sep 30, 2020 | 18.54B | 605.00M | 3.37% |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
| Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.79B |
| SS Innovations International | 16.04M |
| Veradigm | 1.53B |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| BioStem Technologies | 210.49M |
| SANUWAVE Health | 29.30M |
Coloplast News
- 19 days ago - Coloplast targets 8%-9% organic growth for FY 2025 amid Kerecis expansion and new launches - Seeking Alpha
- 19 days ago - Coloplast A/S (CLPBF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Coloplast A/S GAAP EPS of DKK4.63, revenue of DKK7.03B - Seeking Alpha
- 19 days ago - Coloplast Finance B.V. - Interim Financial Report, Q1 2024/25 - GlobeNewsWire
- 20 days ago - Coloplast A/S - Allocation of Share Options - GlobeNewsWire
- 20 days ago - Coloplast A/S - Interim Financial Report, Q1 2024/25 - GlobeNewsWire
- 4 weeks ago - Brett Girard's Past Picks: Coloplast A/S, Telus and Littlefuse - BNN Bloomberg
- 4 weeks ago - Coloplast A/S - Q1 2024/25 Earnings Release - Invitation to conference call on 4 February 2025 at 11.00am CET (correction) - GlobeNewsWire